P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes

Por Franti, M, Nandi, A, Smith, L, Lilja, A, Balsitis, S, Dey, A, Zambonelli, C, Srivastava, I, Barnett, SW
Publicado em 2009

Rationally designed HIV envelope glycoproteins delivered in a novel adjuvant elicited more broadly reactive antigen-specific antibody responses

Por Dey AK, Kassa A, Nandi A, Sun Y, Labranche C, Hartog K, Montefiori D, Carfi A, Srivastava I, Barnett SW
Publicado em 2012-09-01

Rationally designed HIV envelope glycoproteins delivered in a novel adjuvant elicited more broadly reactive antigen-specific antibody responses

Por Dey, AK, Kassa, A, Nandi, A, Sun, Y, Labranche, C, Hartog, K, Montefiori, D, Carfi, A, Srivastava, I, Barnett, SW
Publicado em 2012

Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T- and B-cell responses

Por Bogers, WM, Oostermeijer, H, Mooij, P, Koopman, G, Verschoor, E, Davis, D, Heeney, JL, Cu, Y, Banerjee, K, Burke, B, Dey, A, Geall, A, Barnett, SW
Publicado em 2012

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

Por Banerjee, K, Cu, Y, Sun, Y, Hartog, K, Dey, A, Brito, L, Verma, A, Nandi, A, Sarkar, P, Valiante, NM, Geall, AJ, Barnett, SW, Otten, GR
Publicado em 2012

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660

Por Banerjee, K, Balsitis, S, Jamil, T, Jones, C, Dey, A, Flandez, J, Brito, L, Cu, Y, Beard, C, Santra, S, Pal, R, Miller, N, Valiante, NM, Mason, P, Barnett, SW, Otten, GR
Publicado em 2012

Reinventing the nucleic acid vaccine with self-amplifying RNA

Por Geall, AJ, Otten, GR, Hekele, A, Bogers, W, Oostermeijer, H, Mooij, P, Gerrit, K, Verschoor, E, Banerjee, K, Cu, Y, Beard, CW, Brito, LA, Ulmer, JB, Mandl, CW, Barnett, SW
Publicado em 2012